A comprehensive view of Clinical Trials. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
INTERNATIONAL PATENT: BRISTOL-MYERS SQUIBB COMPANY FILES APPLICATION FOR "COMBINATION THERAPY WITH SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS"
Published:
May 20, 2024
by U.S. Fed News
|
J&J to acquire Proteologix for US$850.0M; deal adds bispecific antibodies to J&J's portfolio, including PX128, a bispecific antibody ready to enter Phase 1 development and PX130, which is in preclinical development
Published:
May 17, 2024
by Associated Press
|
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
Published:
May 17, 2024
by BioNTech SE
|
California Supreme Court to review decision allowing plaintiffs to sue pharmaceutical manufacturers for delaying development of new drugs; Gilead Life Sciences case may set precedent
Published:
May 16, 2024
by Mondaq Business Briefing
|
Bristol Myers Squibb announces 4-year results from POETYK PSO trial of Sotyktu in moderate-to-severe plaque psoriasis patients; trial shows 71.7% achieved PASI 75 and 47.5% achieved PASI 90 at Week 208
Published:
May 16, 2024
by Bristol-Myers Squibb Co.
|
Ask us about our Government & Public Policy market view